GGrantIndex
← Leaderboards

Brooke L Fridley

H. Lee Moffitt Cancer Ctr & Res Inst

$4,952,468
Attributed
$7,088,391
Total exposure
12
Grants
11
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY200925
$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$7,088,391 · 12

By mechanism

R01$1,616,585 · 1
P30$1,497,708 · 4
T32$1,389,118 · 1
U01$1,218,831 · 1
R21$907,852 · 3
P01$458,297 · 2

Top collaborators

Most similar at H. Lee Moffitt Cancer Ctr & Res Inst

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsResearch PersonnelGenomicsComputer SoftwareEnsureDesignMethodologyData AnalysesProgramsSamplingFacultyCancer CenterResearch Project GrantsServicesBioinformaticsResearch SupportMemberPhenotypeCancer PatientAnticancer ResearchCollaborationsStatistical MethodsResponseCells

Grant awards (33)

Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer$533,867
R01 · FY2025 · CA · contact PI
Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer$508,680
R01 · FY2024 · CA · contact PI
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics$397,545
U01 · FY2024 · CA
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics$405,558
U01 · FY2023 · CA
Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer$304,046
R01 · FY2023 · CA · contact PI
Spatial and Bayesian modeling methods for assessment of the tumor immune microenvironment and survival of women with ovarian cancer$269,992
R01 · FY2023 · CA · contact PI
Data Science Core$154,984
P01 · FY2023 · CA · contact PI
Biostatistics & Bioinformatics Shared Resource$1
P30 · FY2023 · CA · contact PI
Integrated Program in Cancer and Data Science$441,104
T32 · FY2022 · CA
Analytical tools for studying the tumor microenvironment leveraging spatial transcriptomics$415,728
U01 · FY2022 · CA · contact PI
Biostatistics & Bioinformatics Shared Resource$162,193
P30 · FY2022 · CA · contact PI
Data Science Core$150,345
P01 · FY2022 · CA · contact PI
Integrated Program in Cancer and Data Science$427,875
T32 · FY2021 · CA
Biostatistics Core$191,533
P30 · FY2021 · CA · contact PI
Core 004 (377) Cancer Informatics$168,918
P30 · FY2021 · CA · contact PI
Data Science Core$152,968
P01 · FY2021 · CA · contact PI
Cancer Research Workforce Development in FAIR Artificial Intelligence and Machine Learning$86,337
T32 · FY2021 · CA
Integrated Program in Cancer and Data Science$294,797
T32 · FY2020 · CA
Biostatistics Core$191,529
P30 · FY2020 · CA · contact PI
Core 004 (377) Cancer Informatics$168,914
P30 · FY2020 · CA · contact PI
Biostatistics Core$4,498
P30 · FY2020 · CA · contact PI
Core 004 (377) Cancer Informatics$4,498
P30 · FY2020 · CA · contact PI
Integrated Program in Cancer and Data Science$139,005
T32 · FY2019 · CA
Biostatistics & Informatics Shared Resource$289,662
P30 · FY2018 · CA · contact PI
Biostatistics & Informatics Shared Resource$16,667
P30 · FY2018 · CA · contact PI
Biostatistics & Informatics Shared Resource$269,077
P30 · FY2017 · CA · contact PI
Biostatistics & Informatics Shared Resource$30,218
P30 · FY2017 · CA · contact PI
Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty$212,938
R21 · FY2015 · CA · contact PI
Bayesian Integrative Clustering for Determining Molecular Based Cancer Subty$164,213
R21 · FY2014 · CA · contact PI
Bayesian hierarchical nonlinear models for pharmacogenomic cytotoxicity studies$113,250
R21 · FY2012 · GM · contact PI
Bayesian hierarchical nonlinear models for pharmacogenomic cytotoxicity studies$118,275
R21 · FY2011 · GM · contact PI
Integrative genomic models for analysis of pharmacogenomic studies$166,210
R21 · FY2010 · CA · contact PI
Integrative genomic models for analysis of pharmacogenomic studies$132,966
R21 · FY2009 · CA · contact PI